AMPH: Amphastar Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,016.30
Enterprise Value ($M) 991.41
Book Value ($M) 387.85
Book Value / Share 8.21
Price / Book 2.97
NCAV ($M) 115.12
NCAV / Share 2.45
Price / NCAV 8.83

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.02

Liquidity (mrq)
Quick Ratio 1.83
Current Ratio 2.81

Balance Sheet (mrq) ($M)
Current Assets 284.13
Assets 601.30
Liabilities 169.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 294.67
Operating Income -8.62
Net Income -6.66
Earnings Per Share Basic -0.12
Earnings Per Share Diluted -0.12

Cash Flow Statement (mra) ($M)
Cash From Operations 38.19
Cash from Investing -42.18
Cash from Financing -42.18

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-13 13G/A Zhang Jack Y. 27.30 3.74
2019-01-24 13G/A BlackRock Inc. 12.90 7.47

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-08-09 10-Q AMPH / Amphastar Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-05-10 10-Q AMPH / Amphastar Pharmaceuticals, Inc. 10-Q Quarterly Report 10-Q
2019-03-15 10-K AMPH / Amphastar Pharmaceuticals, Inc. 10-K (Annual Report)
2018-11-09 10-Q AMPH / Amphastar Pharmaceuticals, Inc. 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
AMAG – AMAG Pharmaceuticals, Inc. AMBI – Ambit Biosciences Corp
AMGN – Amgen Inc. AMRN – Amarin Corp. Plc
ANAC – Anacor Pharmaceuticals, Inc.


Financial data and stock pages provided for FREE by
Fintel.io